Etretinate

CAS No. 54350-48-0

Etretinate ( Ethyl etrinoate; HSDB 7185; HSDB7185; Ro 10-9359 )

Catalog No. M18769 CAS No. 54350-48-0

Etretinate is a RAR and RXR agonist previoulsy used to treat psoriasis. It induces brth defects and suppresses proliferation in cutaneous T-cell lymphoma models.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 45 In Stock
25MG 61 In Stock
50MG 81 In Stock
100MG 129 In Stock
200MG 221 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Etretinate
  • Note
    Research use only, not for human use.
  • Brief Description
    Etretinate is a RAR and RXR agonist previoulsy used to treat psoriasis. It induces brth defects and suppresses proliferation in cutaneous T-cell lymphoma models.
  • Description
    Etretinate is a RAR and RXR agonist previoulsy used to treat psoriasis. It induces brth defects and suppresses proliferation in cutaneous T-cell lymphoma models.
  • Synonyms
    Ethyl etrinoate; HSDB 7185; HSDB7185; Ro 10-9359
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    54350-48-0
  • Formula Weight
    354.48
  • Molecular Formula
    C23H30O3
  • Purity
    98%
  • Solubility
    ——
  • SMILES
    CCOC(=O)/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C(=C(C=C1C)OC)C)C
  • Chemical Name
    ethyl (2E,4E,6E,8E)-9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethylnona-2,4,6,8-tetraenoate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Kaempferidinidin chl...

    Reference standards.

  • 5-O-Coumaroylquinic ...

    5-O-Coumaroylquinic acid has a considerable inhibitory effect on PTP1B.5-O-Coumaroylquinic acid( 3-O-Coumaroylquinic acid) shows a significant concentration-dependent inhibitory effect on α-glucosidase, so it has anti-hyperglycemic effect.5-O-Coumaroylquinic acid(3-O-Coumaroylquinine acid) enhances glucose uptake and inhibits PTP1B in vitro.

  • N-Acetyl-L-ornithine

    N-Acetylornithine is a minor component of deproteinized blood plasma of human blood. Human blood plasma contains a variable amount of acetylornithine averaging 1.1 +/- 0.4 μmol/L.